YD Bio to Merge with EG BioMed

YD Bio entered a memorandum of understanding to merge with EG BioMed in a combination intended to advance DNA methylation-driven AI platforms for cancer diagnostics and drug development. The ...

YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development

YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that the ...

YD Bio Limited: YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation-Driven AI Platforms for Cancer Diagnostics and Drug Development

YD Bio Limited ("YD Bio" or the "Company") (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic ...
Open Access Government

Measuring the future: Nanoscale metrology and the global race for technological competitiveness

Cecilia Van Cauwenberghe explains how to measure the future using nanoscale metrology and discusses the global competition ...
Conventus Law

India – Technical Considerations Achieved By Technical Means Implemented On A Computer Patentable: Madras High Court Rules.

Technical Considerations Achieved By Technical Means Implemented On A Computer Patentable: Madras High Court Rules. Legal ...
NERDBOT

The Science Behind Immersive Addiction Therapy Programs

Explore the science behind immersive addiction therapy programs, how evidence-based approaches improve treatment outcomes, ...